TMEM184B and cancer: In a study of miRNA‐26a/b in oral SCC, Fukumoto et al.29reported that the silencing of TMEM184B could inhibit the migration and invasive ability of cancer cells and regulate gene expression in the actin cytoskeleton pathway.